Adicet Bio, Inc. (ACET) vs RenovoRx, Inc. (RNXT)
Adicet Bio, Inc. and RenovoRx, Inc. are both Biotechnology companies. Adicet Bio, Inc. and RenovoRx, Inc. are of similar size ($77.4M and $75.8M). Adicet Bio, Inc. has the higher net margin (0.00% vs −621.7%) and the lower return on invested capital (−2,518.2% vs 0.00%). Across the 16 metrics below, Adicet Bio, Inc. leads on 10 and RenovoRx, Inc. on 6.
Valuation
Profitability
| Metric | ACET | RNXT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 84.41% | 65.16% |
| Operating margin | 0.00% | (685.22%) | 0.00% |
| Net margin | 0.00% | (621.71%) | 0.00% |
| Free cash flow margin | 0.00% | (604.10%) | 0.00% |
| Return on equity | (78.08%) | (125.23%) | (57.72%) |
| Return on assets | (63.62%) | (97.83%) | (49.22%) |
| Return on invested capital | (2,518.16%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack